Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Medicine is experiencing a period of change: Extensive molecular biological data on the patient are increasingly included in diagnosis and treatment. This trend is based on the development of targeted drugs and accompanying diagnostics, which serve the purpose of providing advance evidence that the medication promises therapy success for the patient. According to this concept drugs are often given in combination. The sizes of patient groups for which a given therapy out of many possible alternatives can be expected to be successful are quite limited. The relationship between the molecular data pertaining to a patient and their disease phenotype are complex and cannot be determined manually. Thus, computer-based bioinformatics methods play a central role in interpreting the molecular data and as an instrument for providing recommendations for the practicing physician. Bioinformatics is an essential component in basic research, in the development of new concepts for diagnosis and therapy as well as in clinical practice, in which these concepts are applied to treating patients. This article discusses the role of bioinformatics in both basic research and clinical practice. We present the example of treatment of HIV patients, for which bioinformatics-assisted therapy selection has already entered clinical practice. Such a therapy concept is also predestined for other diseases (e.g., cancer). The article concludes with remarks on the prerequisites for society as a whole for ensuring success of this concept of personalised medicine as a factor of medical progress.
Medicine is experiencing a period of change: Extensive molecular biological data on the patient are increasingly included in diagnosis and treatment. This trend is based on the development of targeted drugs and accompanying diagnostics, which serve the purpose of providing advance evidence that the medication promises therapy success for the patient. According to this concept drugs are often given in combination. The sizes of patient groups for which a given therapy out of many possible alternatives can be expected to be successful are quite limited. The relationship between the molecular data pertaining to a patient and their disease phenotype are complex and cannot be determined manually. Thus, computer-based bioinformatics methods play a central role in interpreting the molecular data and as an instrument for providing recommendations for the practicing physician. Bioinformatics is an essential component in basic research, in the development of new concepts for diagnosis and therapy as well as in clinical practice, in which these concepts are applied to treating patients. This article discusses the role of bioinformatics in both basic research and clinical practice. We present the example of treatment of HIV patients, for which bioinformatics-assisted therapy selection has already entered clinical practice. Such a therapy concept is also predestined for other diseases (e.g., cancer). The article concludes with remarks on the prerequisites for society as a whole for ensuring success of this concept of personalised medicine as a factor of medical progress.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.